A prospective study investigating gross motor function of children with cerebral palsy and GMFCS level II after long-term Botulinum toxin type A use.
Jane ValentineSue-Anne DavidsonNatasha BearEve BlairLisa PatersonRoslyn WardDavid ForbesCatherine ElliottPublished in: BMC pediatrics (2020)
This cohort study has confirmed that children with Cerebral Palsy, Gross Motor Function level II treated at a young age with repeated doses of Botulinum Toxin A within an integrated comprehensive service, maintain or improve their functional motor level at a later age.